# A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

> **NCT05155306** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1358894, intended Commercial Formulation (iCF) (T)
- **DRUG:** BI 1358894, Trial Formulation 2 (TFII) (R)

## Key facts

- **NCT ID:** NCT05155306
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-14
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155306, "A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05155306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*